| #30 |
David Esopi |
Regeneron Pharmaceuticals |
1 |
| #30 |
Matthew Baird |
Cornell University |
1 |
| #30 |
Gokul B. Kandiraju |
IBM |
1 |
| #30 |
Christina Passno |
Regeneron Pharmaceuticals |
1 |
| #30 |
Nathan David |
— |
1 |
| #30 |
Petar K. Pepeljugoski |
IBM |
1 |
| #30 |
Olukayode Sosina |
Regeneron Pharmaceuticals |
1 |
| #30 |
Toshio Kimura |
Regeneron Pharmaceuticals |
1 |
| #30 |
Claudia Schurmann |
Regeneron Pharmaceuticals |
1 |
| #30 |
Hema Raghavan |
IBM |
1 |
| #30 |
Nitin K. SWARNAKAR |
Tesorx Pharma |
1 |
| #30 |
Priscilla D. Antunez |
IBM |
1 |
| #30 |
Nithya Rajamani |
IBM |
1 |
| #30 |
Jaime Masferrer |
G.D. Searle |
1 |
| #30 |
Peter H.A. Yang |
Regeneron Pharmaceuticals |
1 |
| #30 |
Chad May |
Takeda Pharmaceutical Company Limited |
1 |
| #30 |
Galina Grishina |
Icahn School Of Medicine At Mount Sinai |
1 |
| #30 |
Puchun Liu |
Emisphere Technologies |
1 |
| #30 |
Daniel A. Schwemmer Gipe |
Regeneron Pharmaceuticals |
1 |
| #30 |
Li-Cheng Richard Zai |
IBM |
1 |
| #30 |
Stanley Joe Johnson |
Express Scripts Strategic Development |
1 |
| #30 |
Kavita Praveen |
Regeneron Pharmaceuticals |
1 |
| #30 |
Kishor Devalaraja-Narashimha |
Regeneron Pharmaceuticals |
1 |
| #30 |
Parsa Akbari |
Regeneron Pharmaceuticals |
1 |
| #30 |
Rehan K. Jaffri |
Symbol Technologies |
1 |